To interpret the data, we need to consider the factors described above, namely, isoflavone dose, forms and sources of isoflavone, timing of isoflavone exposure, and the equol-producer status, estrogen-receptor status, and hormonal profile of individuals, as these are all factors that potentially modulate the association between soy intake and breast cancer risk. The gene discussed is ESR1; the disease is breast cancer.